slider-news-list.png

NEWS

Сомраny News

Patent news - Israel

Ovoca Bio plc is pleased to announce that on 1st March 2019 its subsidiary, IVIX, was granted patent No 234753 in Israel covering any use for a large list of peptide variants based on BP-101.

May 7, 2019
More...
US AND EU CLINICAL DEVELOPMENT PLANS

Ovoca Bio plc is pleased to announce that its subsidiary IVIX has commenced the process of preparing an integrated Clinical Development Plan (“CDP”) for its investigational drug candidate, Libicore (BP-101), for both the US and EU regions with Biorasi LLC (“Biorasi”), an experienced US-based contract research organization.

April 23, 2019
More...
Ovoca Presents at BIO-Europe Spring® 2019, Vienna

Ovoca Presents at BIO-Europe Spring® 2019, Vienna

April 15, 2019
More...
Pages: Prev. 1 2 3 Next